Russell Investments Group
GH icon

Russell Investments Group’s Guardant Health GH Stock Holding History

Russell Investments Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.5M Buy
210,062
+21,922
+12% +$2.38M 0.03% 560
2026
Q1 		$17.4M Sell
188,140
-23,252
-11% -$2.33M 0.02% 696
2025
Q4 		$21.6M Buy
211,392
+16,157
+8% +$1.45M 0.02% 593
2025
Q3 		$12.2M Buy
195,235
+90,931
+87% +$4.95M 0.01% 819
2025
Q2 		$5.43M Buy
104,304
+30,802
+42% +$1.38M 0.01% 1165
2025
Q1 		$3.13M Buy
73,502
+39,234
+114% +$1.69M ﹤0.01% 1454
2024
Q4 		$1.05M Sell
34,268
-5,127
-13% -$144K ﹤0.01% 1993
2024
Q3 		$904K Buy
39,395
+1,335
+4% +$37.8K ﹤0.01% 2068
2024
Q2 		$1.1M Buy
38,060
+31
+0.1% +$722 ﹤0.01% 1933
2024
Q1 		$785K Sell
38,029
-13,448
-26% -$288K ﹤0.01% 2062
2023
Q4 		$1.39M Sell
51,477
-47,916
-48% -$1.26M ﹤0.01% 1808
2023
Q3 		$2.95M Sell
99,393
-29,389
-23% -$1.03M 0.01% 1344
2023
Q2 		$4.61M Sell
128,782
-19,122
-13% -$549K 0.01% 1135
2023
Q1 		$3.47M Buy
147,904
+147,446
+32,193% +$4.21M 0.01% 1274
2022
Q4 		$12.5K Hold
458
– – ﹤0.01% 2835
2022
Q3 		$24K Hold
458
– – ﹤0.01% 2798
2022
Q2 		$18K Hold
458
– – ﹤0.01% 2808
2022
Q1 		$30K Sell
458
-3,006
-87% -$206K ﹤0.01% 2658
2021
Q4 		$346K Hold
3,464
– – ﹤0.01% 2554
2021
Q3 		$432K Sell
3,464
-537
-13% -$63.8K ﹤0.01% 2530
2021
Q2 		$495K Sell
4,001
-2,068
-34% -$278K ﹤0.01% 2602
2021
Q1 		$924K Buy
6,069
+4,249
+233% +$642K ﹤0.01% 2282
2020
Q4 		$234K Sell
1,820
-296
-14% -$34.1K ﹤0.01% 2714
2020
Q3 		$236K Buy
2,116
+1,820
+615% +$166K ﹤0.01% 2711
2020
Q2 		$24K Hold
296
– – ﹤0.01% 3041
2020
Q1 		$20K Buy
+296
New +$22.7K ﹤0.01% 2951

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Russell Investments Group's GH Position: Q2 2026 in Review

Russell Investments Group increased its Guardant Health (GH) stake by 12% in Q2 2026, buying an estimated $2.38M and bringing the position to 210,062 shares worth $31.5M. The position accounts for 0.03% of the portfolio, ranked #560.

Russell Investments Group first reported a position in GH in Q1 2020 and has held it in 26 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Russell Investments Group held 210,062 shares of Guardant Health worth $31.5M as of Q2 2026.
  • Russell Investments Group bought 21,922 Guardant Health shares in Q2 2026, an estimated $2.38M.
  • Guardant Health made up 0.03% of Russell Investments Group's portfolio in Q2 2026, its #560 holding.
  • Russell Investments Group first reported a position in Guardant Health in Q1 2020 and has held it in 26 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.